BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38057778)

  • 1. Correlation between white matter hyperintensity and delusional symptoms in Alzheimer's disease.
    Fan W; Ma S; Wang Z; Han Y; Liu X; Gu R; Cai Q
    BMC Psychiatry; 2023 Dec; 23(1):914. PubMed ID: 38057778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Spectrum of Subcortical Hyperintensities and Cognitive Decline.
    Chen YC; Tsao HH; Chu YC; Wang JJ; Lee JD; Chang PY; Hsu WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):130-138. PubMed ID: 29061091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
    Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
    Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal white matter hyperintensity predicts lower urinary tract dysfunction in older adults with amnestic mild cognitive impairment and Alzheimer's disease.
    Ogama N; Yoshida M; Nakai T; Niida S; Toba K; Sakurai T
    Geriatr Gerontol Int; 2016 Feb; 16(2):167-74. PubMed ID: 25613527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
    Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
    JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
    Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
    Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
    Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults.
    Van Etten EJ; Bharadwaj PK; Hishaw GA; Huentelman MJ; Trouard TP; Grilli MD; Alexander GE
    Hippocampus; 2021 May; 31(5):469-480. PubMed ID: 33586848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
    Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort.
    Salvadó G; Brugulat-Serrat A; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Alzheimers Res Ther; 2019 Jan; 11(1):12. PubMed ID: 30678723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer's disease with white matter hyperintensities.
    Ha SY; Youn YC; Kim S; Hsiung GY; Ahn SW; Shin HW; Park KY; Park TH; Kim SS; Kee BS; Kwon OS
    J Clin Neurosci; 2012 Nov; 19(11):1506-10. PubMed ID: 22989793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    Yang HJ; Lee S; Koh MJ; Lee HK; Kim BS; Kim KW; Park JH
    J Alzheimers Dis; 2021; 83(3):1281-1289. PubMed ID: 34420961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study.
    Kaskikallio A; Karrasch M; Koikkalainen J; Lötjönen J; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
    Dement Geriatr Cogn Disord; 2019; 48(5-6):297-307. PubMed ID: 32209796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional brain atrophy in patients with mild Alzheimer's disease and delusions.
    Geroldi C; Bresciani L; Zanetti O; Frisoni GB
    Int Psychogeriatr; 2002 Dec; 14(4):365-78. PubMed ID: 12670058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
    Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
    Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.